Search results for 4-1BB

Anti-Mouse CD137/4-1BB/TNFRSF9 Antibody (LOB12.3), PE (MC336127), abinScience, MC336127

Purified anti-human CD137 (4-1BB) Recombinant Antibody, CD137, QA18A49, BioLegend, 370902

QA18A49 clone of antibody is able to completely block the binding of clone 4B4-1 to CD137 on cell surface.

Research Grade Anti-Human CD137/TNFRSF9/4-1BB (AGEN 2373) (HC336106), abinScience, HC336106

InVivo Plus Anti-Mouse CD137/4-1BB/TNFRSF9 Antibody (3H3) (MC336209), abinScience, MC336209

APC anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309809

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

APC anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309810

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

Biotin anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309806

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PE anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309803

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

PE anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309804

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).

Purified anti-human CD137 4-1BB Antibody anti-CD137 - 4B4-1, BioLegend, 309802

Additional reported applications (for the relevant formats) include: immunoprecipitation1,4, inhibition of cytokine production2,3, and ELISA. For most successful immunofluorescent staining results, it may be important to maximize signal over background by using a relatively bright fluorochrome-antibody conjugate (Cat. No. 309804) or by using a high sensitivity, three-layer staining technique (e.g., including a biotinylated anti-mouse IgG second step (Cat. No. 405303), followed by Streptavidin-PE (Cat. No. 405204)).